Evidence map›Paper›PMID 35307754›Full record

ArticleJournal of neurology2022

The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson's disease and controls.

Carl Counsell, Cinzia Giuntoli, Qaisar Imran Khan, Jodi Maple-Grødem, Angus D Macleod

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07659288 (Differential Motor and Cognitive Responses to Two Virtual Reality-Based Rehabilitation Approaches in Parkinson's Disease), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07659288 nacompletednot on this mapstarted 2025, after this paper: background citation

Differential Motor and Cognitive Responses to Two Virtual Reality-Based Rehabilitation Approaches in Parkinson's Disease: A Pilot Comparative Study

TypeinterventionalSponsorNeuro Group XR Inc.Ran2025 to 2025Enrolled16ConditionsParkinson s DiseaseArmsImmersive Virtual Reality, Non-Immersive Virtual Reality
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Carl CounsellInstitute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. carl.counsell@abdn.ac.uk.ORCID http://orcid.org/0000-0001-6622-7839
Cinzia GiuntoliUniversity of Aberdeen Medical School, Foresterhill, Aberdeen, AB25 2ZD, UK.
Qaisar Imran KhanUniversity of Aberdeen Medical School, Foresterhill, Aberdeen, AB25 2ZD, UK.
Jodi Maple-GrødemThe Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
Angus D MacleodInstitute of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.
University of Aberdeen · GBStavanger University Hospital · NO

Funding

British Medical Association Doris Hillier awardChief Scientist Office, Scottish Government Health and Social Care Directorate CAF/12/05Chief Scientist Office, Scottish Government Health and Social Care Directorate PCL/17/10Parkinson's UK G0502Parkinson's UK G0914Parkinson's UK G1302
6 · The paper itself

Abstract

backgroundThere are few long-term data on the incidence, baseline predictors, and outcomes of dementia in Parkinson's disease (PD) from prospective community-based incident cohorts.

methodsThe PINE study prospectively identified all incident PD patients in Aberdeen along with age-sex-matched, community-based controls who consented to standardized annual life-long follow-up. Each year, a clinical expert reviewed the diagnosis of PD and the presence of dementia according to DSM-IV-based criteria. Age-sex stratified incidence rates for dementia in PD and controls were calculated and compared with hazard ratios (HR) adjusted for age, sex, education, and socioeconomic status. Cox proportional-hazard modelling was used to assess baseline predictors for PD dementia and the influence of dementia on survival and institutionalization.

results201 patients (mean age 72.6yrs) and 260 controls (mean age 75.4yrs) were followed for median 9.5 years. The incidence of dementia was 7.4 (PD) versus 2.1 (controls) per 100 person-years (adjusted HR 6.0, 95%CI 4.1-8.7), with a sixfold increase from under 60 to over 80 years in PD but no sex difference. Independent baseline predictors of PD dementia were older age at diagnosis, self-reported cognitive symptoms, dream enactment, lower MMSE scores, worse motor UPDRS scores, and the ApoE genotype. PD dementia increased the rates of subsequent death and institutionalization (32.0 and 26.9 per 100 person-years, respectively).

conclusionThe incidence of dementia in PD is high, increases markedly with age, is increased in those with baseline subjective cognitive symptoms as well as other established risk factors, and is associated with high rates of death and institutionalization.

Indexed as

DementiaParkinson DiseaseAgedCohort StudiesHumansIncidenceProspective StudiesCohort studiesDementiaIncidenceParkinson’s diseasePrediction

Identifiers

PMID35307754
PMCPMC9294013
OpenAlexW4221081868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.